Belgian PE/VC listed on Euronext Brussels (GIMB) since 1980. Manages c.€1.8bn AUM across ~60 portfolio companies. 59-person team across Antwerp, Paris, Frankfurt, London. Notable: Spineart (surgical devices), Exciva (neuro biotech), RoboJob (automation). Platform-driven model; recent strategic adds: Gimv Anchor (long-term growth co-invest w/ WorxInvest). FY24-25 net profit €219m.
Investment Focus
Investment Thesis
Growth & buyout across 5 platforms: Connected Consumer, Healthcare, Smart Industries, Sustainable Cities. Avoids new Life Sciences (ceased Jan 2026). Targets growth-stage, established companies w/ solid market position. Check size €5-150m. DACH-centric (Belgium, France, Germany, Benelux). Patient capital approach; active value-add through bolt-ons & digital transformation. Portfolio avg €3.7b turnover, 60 cos.
Interested in connecting?
Visit their website or reach out directly.